Zobrazeno 1 - 10
of 53
pro vyhledávání: '"R. S. Prichard"'
Autor:
M. R. Boland, A. J. Lowery, S. Walsh, D. Beddy, R. S. Prichard, D. O’Shea, S. J. Skehan, E. W. McDermott
Publikováno v:
Case Reports in Surgery, Vol 2014 (2014)
An adrenal “incidentaloma” is defined as an unexpected finding on radiological imaging performed for unrelated indications. Improvements in radiological technology have seen a dramatic increase in this phenomenon. We report the unique case of a 6
Externí odkaz:
https://doaj.org/article/2ec413a02b4b4523aab713eba787ae22
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-4 (2021)
Endocrinology, Diabetes & Metabolism Case Reports
Endocrinology, Diabetes & Metabolism Case Reports
Summary Multiple endocrine neoplasia type 1 (MEN1) is a rare inherited endocrine disorder with a high rate of penetrance. The incidence of MEN1 is 1/30,000 in the general population; however, it is quite rare for a patient to present for medical atte
Autor:
Boland, Ishwarya Balasubramanian, James Geraghty, Enda W. McDermott, Damian McCartan, S Doyle, Denis Evoy, G Hanley, R. S. Prichard
Publikováno v:
British Journal of Surgery. 108
Introduction Recent studies have suggested that sentinel lymph node biopsy (SLNB) can be omitted in newly diagnosed elderly breast cancer (BC) patients as it may not influence decisions regarding further therapeutic intervention. The aim of this stud
PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4094::95a226e00e475e3e17a1e5e6c5b859b0
http://hdl.handle.net/11585/804886
http://hdl.handle.net/11585/804886
Benign goiter remains a major public health issue around the globe. Bilateral subtotal thyroidectomy for management of goiter is associated with a high recurrence rate. Total thyroidectomy has now become the preferred surgical approach for treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4706c057dfcca299098f141e2ea85ad
https://doi.org/10.1016/b978-0-323-66127-0.00009-0
https://doi.org/10.1016/b978-0-323-66127-0.00009-0
Autor:
Michael R. Boland, R. S. Prichard, Damian McCartan, Denis Evoy, Enda W. McDermott, James Geraghty, Éanna J Ryan, Ishwarya Balasubramanian, Tim Harding
Publikováno v:
Clinical breast cancer. 21(4)
The association between immediate breast reconstruction (IBR)-related wound complications and breast cancer recurrence (BCR) remains uncertain. This study aimed to investigate the oncological outcomes in patients with wound complications following ma
Autor:
Aoife Maguire, Dhaffir Alazawi, Michael R. Boland, T. Boyle, Johnny O’Mahony, Damian McCartan, James Geraghty, Elizabeth Connolly, Sylvia O'Keeffe, Jack Nolan, Enda W. McDermott, R. S. Prichard, Denis Evoy, Charles C. Gillham, Timothy Nugent
Publikováno v:
Breast cancer (Tokyo, Japan). 28(1)
Breast fibromatosis is a rare clinical entity, but poses significant diagnostic and therapeutic challenges. In light of recent changes in management practices, the aim was to review our institutional experience of breast fibromatosis and provide a re
Publikováno v:
World journal of surgery. 44(5)
Neoadjuvant chemotherapy (NAC) can improve cosmesis by reducing resection volume. Breast-conserving surgery (BCS) aims to achieve clear excision margins while optimizing cosmesis. However, the influence of NAC on margin re-excision after BCS is uncle
Autor:
Denis Evoy, James Geraghty, Enda W. McDermott, S.R. Tee, R. S. Prichard, Liam A Devane, Jane Rothwell
Publikováno v:
British Journal of Surgery. 105:1541-1552
Background Neoadjuvant chemotherapy for breast cancer has the potential to achieve a pathological complete response in up to 40 per cent of patients, converting disease that was initially node-positive to node-negative. This has raised the question o
Autor:
James Geraghty, Denis Evoy, J. Ballot, Janice M. Walshe, D. McDonnell, R. S. Prichard, John Crown, Kate O'Mahony, Giuseppe Gullo, Reetesh Bose, John Amstrong, D. Tryfonopoulos, Lisa A. Hammond, David Fennelly, Naomi Walsh, Cecily Quinn, Enda W. McDermott, N. Silva
Publikováno v:
British Journal of Cancer
Background The optimal timing of (neo)adjuvant trastuzumab initiation with respect to chemotherapy and surgery remains undefined. Methods Retrospective analysis of a large institutional database of HER2-positive patients who received anti-HER2 therap